Published in Infect Immun on July 01, 1994
Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect Immun (1999) 1.15
Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases. J Neuroimmune Pharmacol (2008) 0.77
Western blot analysis of antibody response to pneumococcal protein antigens in a murine model of pneumonia. Clin Diagn Lab Immunol (1997) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med (1964) 7.18
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med (1980) 5.32
Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem (1986) 4.11
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med (1988) 3.14
Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis (1990) 2.72
A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods (1980) 2.65
Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis (1990) 2.02
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun (1986) 1.79
Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med (1984) 1.73
Standardization of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J (1989) 1.51
Genetic control of the susceptibility to pneumococcal infection. Curr Top Microbiol Immunol (1986) 1.50
Virulence, immunity, and vaccine related to Streptococcus pneumoniae. Crit Rev Microbiol (1991) 1.38
Idiotypic regulation by isologous monoclonal anti-idiotope antibodies. Nature (1981) 1.31
Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J Med Microbiol (1989) 1.30
Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis (1987) 1.30
Pneumococcal polysaccharide vaccines. Rev Infect Dis (1989) 1.29
Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest (1983) 1.28
Secretory IgA and IgM antibodies to E. coli O and poliovirus type I antigens occur in amniotic fluid, meconium and saliva from newborns. A neonatal immune response without antigenic exposure: a result of anti-idiotypic induction? Clin Exp Immunol (1986) 1.22
Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b. J Pediatr (1985) 1.21
Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children. J Infect Dis (1984) 1.18
Capsular polysaccharides as vaccine candidates. Curr Top Microbiol Immunol (1990) 1.17
IgG and IgM pneumococcal polysaccharide antibody responses in infants. Pediatr Res (1984) 1.16
Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun (1984) 1.12
Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates. Infect Immun (1989) 1.07
Immune response of neonates to pneumococcal polysaccharide-protein conjugate. Immunology (1982) 1.05
Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. J Pediatr (1987) 0.98
Antigen requirements for priming of IgG producing B memory cells specific for Type III pneumococcal polysaccharide. Immunology (1980) 0.96
Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child (1983) 0.95
Maternal immunization and the immune response of neonates to pneumococcal polysaccharides. Rev Infect Dis (1987) 0.92
Enhanced antibody response in the offspring of immunized rats. J Immunol (1971) 0.91
Studies on vaccine control and immunogenicity of polysaccharides of Streptococcus pneumoniae. Rev Infect Dis (1981) 0.90
The specific capsular polysaccharide of Streptococcus pneumoniae type 9V. Can J Biochem (1981) 0.88
Maternal immunization to prevent neonatal infections. N Engl J Med (1988) 0.86
Polyvalent group B streptococcal immune globulin for intravenous administration: overview. Rev Infect Dis (1990) 0.84
Human-isotype-specific enzyme immunoassay for antibodies to pneumococcal polysaccharides. J Clin Microbiol (1988) 0.83
Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide. J Clin Microbiol (1991) 0.83
IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals. Scand J Immunol (1990) 0.82
Characterization of the binding of and the immune response to pneumococcal group 9 capsular polysaccharides. Mol Immunol (1987) 0.77
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res (2011) 9.24
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol (1978) 5.82
Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res (1993) 5.01
The time trade-off method: results from a general population study. Health Econ (1996) 4.17
Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol (1997) 3.37
Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences. Nat Genet (2000) 2.82
The mouse intestinal microflora with emphasis on the strict anaerobes. J Exp Med (1971) 2.46
Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun (1991) 2.32
Valuing health states: a comparison of methods. J Health Econ (1996) 2.17
A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making (2001) 1.94
Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci U S A (2000) 1.93
Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol (1990) 1.90
Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. Br J Rheumatol (1998) 1.78
Health state valuations from the general public using the visual analogue scale. Qual Life Res (1996) 1.71
Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci (2001) 1.68
Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons. Cell (1996) 1.63
Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun (1979) 1.61
Lasting biological effects of early environmental influence. 3. Metabolic responses of mice to neonatal infection with a filterable weight-depressing agent. J Exp Med (1968) 1.56
Identification of human pancreatic cancer stem cells. Methods Mol Biol (2009) 1.51
Cost versus benefit in non-surgical management of patients with cancer. BMJ (1988) 1.50
Synaptic strengthening through activation of Ca2+-permeable AMPA receptors. Nature (1996) 1.50
Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat Neurosci (2001) 1.48
The role of Müller's muscle reconsidered. Plast Reconstr Surg (1998) 1.45
Hemin utilization is related to virulence of Streptococcus pneumoniae. Infect Immun (1993) 1.45
ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J Neurosci (1997) 1.45
HHV-8 in lymphoproliferative lesions in skin. Lancet (1996) 1.43
Hemorrhage in normal man. I. distribution and dispersal of saline infusions following acute blood loss: clinical kinetics of blood volume support. Ann Surg (1966) 1.41
[Scleroderma]. Z Hautkr (1990) 1.38
Measuring up to the task. Value Health (2001) 1.38
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Characterization of the cross-reaction between type 19F(19) and 19A(57) pneumococcal capsular polysaccharides: compositional analysis and immunological relation determined with rabbit typing antisera. Infect Immun (1978) 1.31
The structures of the cross-reactive types 19 (19F) and 57 (19A) pneumococcal capsular polysaccharides. J Biol Chem (1980) 1.28
Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia (1999) 1.23
"Death" and the valuation of health-related quality of life. Med Care (2001) 1.22
Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res (1995) 1.22
Neck circumference to thyromental distance ratio: a new predictor of difficult intubation in obese patients. Br J Anaesth (2011) 1.21
Measurement of health-related quality of life in the early follow-up of colon and rectal cancer. Dis Colon Rectum (2006) 1.20
Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer (2001) 1.20
Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer (2001) 1.20
Mechanical response of nickel-titanium instruments with different cross-sectional designs during shaping of simulated curved canals. Int Endod J (2009) 1.19
Convergent cortical representation of semantic processing in bilinguals. Brain Lang (1999) 1.18
Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health (2006) 1.18
Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene (1995) 1.17
Lasting biological effects of early environmental influences. IV. Notes on the physicochemical and immunological characteristics of an enterovirus that depresses the growth of mice. J Exp Med (1969) 1.17
Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation. J Immunol (1990) 1.16
A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J Neurosci (1997) 1.14
Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study. J Korean Med Sci (2001) 1.13
Protein metabolism in the offspring of underfed mother rats. J Nutr (1965) 1.13
Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem (1996) 1.11
Airway goblet cell mucin: its structure and regulation of secretion. Eur Respir J (1997) 1.10
Capsular polysaccharides of nongroupable streptococci that cross-react with pneumococcal group 19. J Immunol (1984) 1.10
Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn Mem (1999) 1.09
Papular elastorrhexis: a variant of dermatofibrosis lenticularis disseminata (Buschke-Ollendorff syndrome)? Dermatology (1994) 1.08
Subpopulations of GABAergic and non-GABAergic rat dorsal horn neurons express Ca2+-permeable AMPA receptors. Eur J Neurosci (1999) 1.07
Non-professional identification of malignant melanoma: are wives more attentive? Br J Dermatol (1999) 1.07
Inconsistency and health state valuations. Soc Sci Med (1996) 1.06
Tuberculous aneurysm of the abdominal aorta: endovascular repair using stent grafts in two cases. Korean J Radiol (2001) 1.06
Delayed presentation of cerebral arterial gas embolism following proven intraoperative venous air embolism. J Neurosurg Anesthesiol (1996) 1.06
Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br J Dermatol (1992) 1.05
Immune response of neonates to pneumococcal polysaccharide-protein conjugate. Immunology (1982) 1.05
Automated high-resolution polymerase chain reaction fragment analysis: a method for detecting T-cell receptor gamma-chain gene rearrangements in lymphoproliferative diseases. Am J Pathol (1998) 1.04
Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer (2000) 1.04
Reactive perforating collagenosis--transepidermal elimination of type IV collagen. Clin Exp Dermatol (1996) 1.03
Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides. J Immunol (1981) 1.00
Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy. Br J Cancer (1996) 1.00
Preferences for schizophrenia-related health states: a comparison of patients, caregivers and psychiatrists. Int Clin Psychopharmacol (1996) 1.00
Measuring oral health: does your treatment really make a difference. Br Dent J (1999) 1.00
Cross-reactivity exists between Mlsa and Mlsd lymphocyte-activating determinants as demonstrated by the negative clonal selection of responder cells in a mixed lymphocyte reaction. Transplant Proc (1979) 0.99
Quality of life, sleep, mood and alcohol consumption: a complex interaction. Addict Biol (2002) 0.99
A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation. Oncogene (1995) 0.98
Bone marrow-derived cells as target cells for polynucleotide adjuvants. J Immunol (1971) 0.98
Problems of behaviour, reading and arithmetic: assessments of comorbidity using the Strengths and Difficulties Questionnaire. Br J Educ Psychol (1999) 0.97
Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs. Pharmacology (1973) 0.97
Outdoor activities in childhood: a protective factor for cutaneous melanoma? Results of a case-control study in 271 matched pairs. Br J Dermatol (2001) 0.97
Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J Invest Dermatol (1999) 0.97
The regulation of the immune response of mice to Haemophilus influenzae type b capsular polysaccharide. Immunology (1978) 0.97
Effect of pulsed radiofrequency for postherpetic neuralgia. Acta Anaesthesiol Scand (2008) 0.97
Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal model. Arch Otolaryngol Head Neck Surg (1994) 0.96
Trauma and melanoma formation: a true association? Br J Dermatol (2000) 0.96
The effect of plasticizers on compatibility, mechanical properties, and adhesion strength of drug-free Eudragit E films. Pharm Res (1991) 0.95
Primary tubercolous osteomyelitis of the sternum. J Cardiovasc Surg (Torino) (2001) 0.95
Biocompatibility of Artecoll. Plast Reconstr Surg (1999) 0.94
Quantitative determination of pneumococcal capsular polysaccharides in the polyvalent vaccine. I. Standardization of an immunoelectrophoretic method. J Biol Stand (1980) 0.93
Esophagogastrostomy reconstruction after limited proximal gastrectomy. Hepatogastroenterology (2002) 0.93
Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers. Infect Immun (1982) 0.93
The Bellagio Task Force report on transplantation, bodily integrity, and the International Traffic in Organs. Transplant Proc (1997) 0.93
Endocervical chlamydial deoxyribonucleic acid in infertile women. Fertil Steril (1990) 0.93
Comparison between high and low molecular weight hyaluronates in knee osteoarthritis patients: open-label, randomized, multicentre clinical trial. J Int Med Res (2006) 0.93
Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system. J Control Release (1999) 0.92
Evaluating podiatry services: testing a treatment specific measure of health status. Qual Life Res (2003) 0.92
[Erythema palmare hereditarium ("red palms")]. Hautarzt (2000) 0.92
Differentiation of antibody-forming cells. I. Ratio of precursor cells to antibody-forming cells in the mouse spleen. J Immunol (1968) 0.92
Maternal immunization and the immune response of neonates to pneumococcal polysaccharides. Rev Infect Dis (1987) 0.92
Detection of clonal T cells in lichen planus. Arch Dermatol Res (2000) 0.92
Construction of a deep coverage BAC library from Capsicum annuum, 'CM334'. Theor Appl Genet (2003) 0.91
Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. Neurobiol Dis (2003) 0.91
Lasting biological effects of early environmental influences. V. Viability, growth, and longevity. J Exp Med (1969) 0.91
Immunochemical characterization of cross-reactivity of pneumococcal group 9 capsular polysaccharide types 9N, 9A, 9L, and 9V. Infect Immun (1981) 0.91